Top Markets
Coin of the day
Antisense Therapeutics Limited Antisense Therapeutics Limited

Antisense Therapeutics Limited

ANP
Rankning i aktier #33643
Antisense Therapeutics Limited, an Australian company headquartered in Toorak... Antisense Therapeutics Limited, an Australian company headquartered in Toorak and founded in 2000, specializes in the research and advancement of innovative antisense pharmaceutical drugs. Its primary pipeline asset, ATL1102, is an antisense inhibitor designed to target CD49d, which is currently in Phase II clinical trials for treating various inflammatory conditions such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. Another promising therapeutic in their portfolio is ATL1103, a second-generation antisense drug that aims to block growth hormone receptor expression, thereby lowering insulin-like growth factor-I levels in the blood, and has completed Phase II clinical trials for conditions stemming from excessive growth hormone action.
Aktiekurs
$0.03702159
Senast synkroniserad: 2024-01-29
Marknadsvärde
$7.21M
Förändring (1 dag)
-3.08%
Förändring (1 år)
0.00%
Land
AU
Handel Antisense Therapeutics Limited (ANP)

Kategori

Historik för aktiesplit för Antisense Therapeutics Limited (ANP)
Aktien Antisense Therapeutics Limited (symbol: ANP) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 17, 2026.
En ANP-aktie köpt före Aug 17, 2026 motsvarar nu 0 ANP-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter